News

Patrick Jordan, Chief Executive Officer of Mycovia, discusses the company's strategies on tackling Recurrent Vulvovaginal Candidiasis.

Pharmaceutical companies should consider implementing a structured, semi-automated process for intake of compassionate use requests. says ViiV Healthcare executives.

While the future of the industry is still uncertain, a slew of uplifting ideas around innovation could help turn things around.

All of the latest happenings in the industry, all in one place.

Insights from a roundtable at Halloran’s Clinical Operations Retreat for Executives covering major topics in both clinical design and execution.

Exploring the three most common concerns with the FSP model: resource forecasting, quality and training of staff, and innovation.

Explore the growing interest in better understanding the potential for cardiovascular complications associated with cancer therapies.